最終更新日:2024/07/31
(pharmacology) A monoclonal antibody used in the treatment of chronic lymphocytic leukemia and T-cell lymphoma, targeting CD52.
正解を見る
alemtuzumab
編集履歴(0)
(pharmacology) A monoclonal antibody used in the treatment of chronic lymphocytic leukemia and T-cell lymphoma, targeting CD52.
alemtuzumab